Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

Vertebral Metastasis Clinical Trial

Official title:
Randomized Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months post-treatment.

Clinical Trial Description

Eligible Vertebral Metastatic Lesion/s-> randomized-> SRT versus SRT+ VAP Stereotactic Radiation Therapy(SRT): 16 Gy X 1 Evaluation: prior to treatment; 1 month, 2-4 months, 5-6 months and 1 year post-treatment ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01527292
Study type	Interventional
Source	University of Louisville
Contact
Status	Terminated
Phase	N/A
Start date	February 2012
Completion date	September 2, 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00294151` - Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer	Phase 3
Recruiting	`NCT03951493` - Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases	Phase 3
Recruiting	`NCT05467540` - SPINERY™ A Novel Radio-Frequency Tumor Ablation Device Study	N/A
Terminated	`NCT01654068` - Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine	N/A
Completed	`NCT05985434` - Prospective Observational Study on Vertebral Metastasis